When we lowered EGF concentration in the media (0.4 ng/mL from the previously defined 50 ng/mL), we restored cetuximab sensitivity in our CRC organoids (Figure 4C,D; Figure S12F) with no significant decrease in overall viability in the untreated condition after five days (Figure S10). The gene discussed is EGF; the disease is colorectal carcinoma.